A novel nonstop mutation in TYMP does not induce nonstop mRNA decay in a MNGIE patient with severe neuropathy

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• Cellular quality control mechanisms target aberrant mRNAs, including nonstop mRNA, through pathways like nonstop-mediated decay (NSD).
• Understanding the in vivo consequences of nonstop mutations in human disease is crucial, yet molecular details remain sparsely examined.
• Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare disorder linked to genetic defects affecting mitochondrial function.

Observation:

• A novel homozygous nonstop mRNA mutation (c.1416delC) was identified in the TYMP gene of an MNGIE patient.
• Quantitative analyses revealed unreduced levels of the nonstop mRNA in the patient and heterozygous carriers.
• Absence of thymidine phosphorylase protein in the patient and decreased levels in carriers were observed.

Findings:

• The identified nonstop mRNA mutation in the TYMP gene did not trigger the expected nonstop-mediated decay (NSD) pathway.
• Evidence suggests that cellular control operates at translational or post-translational levels, rather than mRNA degradation.
• This represents the first documented instance of absent NSD in a human disease, indicating exceptions to this surveillance mechanism.

Implications:

• This finding challenges the universal applicability of NSD as a cellular surveillance mechanism for nonstop mRNAs in humans.
• It highlights the potential for alternative regulatory pathways in genetic diseases caused by nonstop mutations.
• Further research into translational and post-translational controls is warranted for understanding and potentially treating such disorders.